Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
Authors:
- 17 April 2008
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 87 (5) , 507-515
Abstract
Since a variety of cell intrinsic and extrinsic molecular abnormalities cooperatively promote tumor formation in multiple myeloma (MM), therapeutic approaches that concomitantly target more than one molecule are increasingly attractive. We herein demonstrate the anti-myeloma effect of a cephalotaxus alkaloid, homoharringtonine (HHT), an inhibitor of protein synthesis, through the induction of apoptosis. HHT significantly reduced Mcl-1, a crucial protein involved in myeloma cell survival, in all three myeloma cell lines examined, whereas certain BH3-only proteins, such as Bim, Bik, and Puma, remained unchanged following HHT treatment, and their expression levels depended on the cell type. HHT also reduced the levels of c-FLIPL/S, activated caspase-8, and induced active truncated-Bid. Thus, HHT-induced apoptosis appears to be mediated via both intrinsic and extrinsic apoptosis pathways, and the resultant imbalance between BH3-only proteins and Mcl-1 may be pivotal for apoptosis by HHT. In addition, HHT treatment resulted in reduced levels of β-catenin and XIAP proteins, which also contribute to disease progression and resistance to chemotherapy in MM. In combination, HHT enhanced the effects of melphalan, bortezomib, and ABT-737. These results suggest that HHT could constitute an attractive option for MM treatment though its ability to simultaneously target multiple tumor-promoting molecules.Keywords
This publication has 50 references indexed in Scilit:
- Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 MimeticsPLOS Medicine, 2007
- NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibitionGenes & Development, 2007
- Rapid Turnover of Mcl-1 Couples Translation to Cell Survival and ApoptosisJournal of Biological Chemistry, 2007
- Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and OsteopontinClinical Cancer Research, 2007
- Homoharringtonine induces apoptosis and growth arrest in human myeloma cellsLeukemia & Lymphoma, 2007
- BH3-only proteins in cell death initiation, malignant disease and anticancer therapyCell Death & Differentiation, 2006
- VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosisBlood, 2004
- Multistep Tumorigenesis of Multiple Myeloma: Its Molecular DelineationInternational Journal of Hematology, 2003
- Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasiaCancer Science, 2003
- A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age‐ and sex‐related differencesBritish Journal of Haematology, 2003